Fluid Management Systems Market: Introduction
Fluid management entails maintenance of normal fluid levels in the body either though administration of intravenous fluids or procedures such as dialysis. Perioperative fluid management, postoperative fluid management, and endoscopic fluid management, management of fluid levels in critically ill patients, fluid management in chronic kidney diseases, and IV therapies for dehydration caused by diarrhea and vomiting are important aspects of the fluid management system.
Read Report Overview - https://www.transparencymarketresearch.com/fluid-management-systemsmarket.html Key Drivers and Restraints of Global Fluid Management Systems Market Rise in number of dialysis centers across the world
The number of dialysis centers is increasing globally. This is projected to drive the fluid management market during the forecast period. According to the Centers for Medicare and Medicaid Services, there were 5,698 dialysis centers in the U.S. in 2010, as against 4,789 dialysis centers in 2005. Furthermore, governments of emerging countries are establishing new dialysis centers and improving current dialysis centers. In 2013, Abu Dhabi Health Services Company and Abu Dhabi General Services Company announced a plan to establish a state-of-the-art dialysis center in Abu Dhabi, the UAE. The dialysis center would consist of 66 kidney dialysis units. Hence, increase in the number of dialysis centers coupled with related initiatives taken by respective governments is anticipated to offer significant opportunities for players in the market. Initiatives have been taken by leading players in the global fluid management systems market to reach maximum ESRD patients across all the regions by increasing dialysis centers. B. Braun Melsungen AG alone has more than 300 centers in Europe, Africa, and Asia Pacific. On World Kidney Day, on March 9, 2017, Fresenius Medical Care launched a brand new Asia Pacific-wide corporate social responsibility initiative through a series of public awareness events reaching 6600 children, parents and carers — as well as media, key renal health partners, and government
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php? flag=B&rep_id=77437 Stringent Regulatory Approval Procedures
Stringent regulatory requirements and the lengthy process of FDA approvals have discouraged OEMs of medical devices in the U.S., who are now eying other regions, such as Asia and Latin America, to launch newer products in the market The major barrier currently faced by orthopedic devices manufacturers is the high investments made for R&D and clinical trials. Slow approval processes are driving costs and minimal return on investment for stakeholders.